An Open Label Phase I Trial of PBI-05204 in Advanced Cancer Patients.
Phase of Trial: Phase I
Latest Information Update: 13 Jun 2014
At a glance
- Drugs PBI 05204 (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 07 Jun 2011 Status changed from active, no longer recruiting to completed, final results have been reported at ASCO 2011.
- 07 Jun 2011 Final results have been reported in an abstract under the Poster Discussion Session, Developmental Therapeutics - Experimental Therapeutics at ASCO 2011.
- 24 May 2011 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov.